Evaluating treatment response to mepolizumab in patients with severe CRSwNP Article

publication date

  • January 1, 2023

webpage

published in

keywords

  • biological products
  • disease-specific quality of life
  • mepolizumab
  • nasal polyps
  • systemic corticosteroid use

start page

  • 108

end page

  • 117

volume

  • 61

issue

  • 2